overview Solid Biosciences: promising biotechnology company
Solid Biosciences (Nasdaq: SLDB) a biotechnology company based in Cambridge, Massachusetts, which is engaged in the search for new methods of therapy for genetic diseases and the development of appropriate medicines. The business was founded in 2013 and went public in 2018 after listing shares on Nasdaq.